articlereponame:Expeditio Repositorio Institucional UJTLJul 23, 2020Closed access

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Abstract

No abstract available for this paper.

Citation impact

536
total citations
FWCI
13.70
Percentile
100%
References
0
Citations per year

Authors

32

Topics & keywords

Keywords
  • Immunogenicity
  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
  • Medicine
  • Coronavirus disease 2019 (COVID-19)
  • 2019-20 coronavirus outbreak
  • Virology
  • Randomized controlled trial
  • Betacoronavirus
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.